| Literature DB >> 32798886 |
Kristen M Valentine1, Michael Croft2, Sujan Shresta3.
Abstract
Pre-existing immunity to dengue virus (DENV) can either protect against or exacerbate, a phenomenon known as antibody dependent enhancement (ADE), a secondary DENV infection. DENV, as an escalating health problem worldwide, has increased the urgency to understand the precise parameters shaping the anti-DENV antibody (Ab) and T cell responses, thereby tipping the balance towards protection versus pathogenesis. Herein, we present the current state of knowledge of about the interplay between the Ab and T cell responses that dictate the outcome of DENV infection and discuss how this newfound knowledge is reshaping strategies for developing safe and effective DENV vaccines.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32798886 PMCID: PMC7655611 DOI: 10.1016/j.coviro.2020.07.018
Source DB: PubMed Journal: Curr Opin Virol ISSN: 1879-6257 Impact factor: 7.090